Research
Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance" > Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance
- First Published August 29, 2019